# Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children

> **NCT00312091** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 44 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Lamivudine, nevirapine, and stavudine fixed-dose tablet
- **DRUG:** Lamivudine
- **DRUG:** Nevirapine
- **DRUG:** Stavudine

## Key facts

- **NCT ID:** NCT00312091
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2021-11-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00312091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00312091, "Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00312091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*